Literature DB >> 11413773

Farming for spare body parts: silk purse or sow's ear.

J P Atkinson1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11413773      PMCID： PMC2194407     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  63 in total

1.  FDA subcommittee finds no evidence of PERV transmission.

Authors:  K Birmingham
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

Review 2.  Role of complement in xenotransplantation.

Authors:  S Saadi; J L Platt
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-12       Impact factor: 2.557

3.  Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology.

Authors:  G Socié; J Y Mary; A de Gramont; B Rio; M Leporrier; C Rose; P Heudier; H Rochant; J Y Cahn; E Gluckman
Journal:  Lancet       Date:  1996-08-31       Impact factor: 79.321

4.  Guidance on xenotransplantation sought.

Authors: 
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

5.  Baboon-to-human cardiac xenotransplantation in a neonate.

Authors:  L L Bailey; S L Nehlsen-Cannarella; W Concepcion; W B Jolley
Journal:  JAMA       Date:  1985-12-20       Impact factor: 56.272

Review 6.  Prospects for xenografting.

Authors:  A Dorling; R I Lechler
Journal:  Curr Opin Immunol       Date:  1994-10       Impact factor: 7.486

7.  Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury.

Authors:  K R McCurry; D L Kooyman; C G Alvarado; A H Cotterell; M J Martin; J S Logan; J L Platt
Journal:  Nat Med       Date:  1995-05       Impact factor: 53.440

8.  Natural history of paroxysmal nocturnal hemoglobinuria.

Authors:  P Hillmen; S M Lewis; M Bessler; L Luzzatto; J V Dacie
Journal:  N Engl J Med       Date:  1995-11-09       Impact factor: 91.245

9.  Expression of the human alpha1,2-fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis.

Authors:  C Costa; L Zhao; W V Burton; K R Bondioli; B L Williams; T A Hoagland; P A Ditullio; K M Ebert; W L Fodor
Journal:  FASEB J       Date:  1999-10       Impact factor: 5.191

10.  Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.

Authors:  M A Davitz; M G Low; V Nussenzweig
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.